http://campath.legalview.com/news-articles/ 2012-02-23 http://campath.legalview.com/news-articles/rxnews-recap-for-01-31-11-biotech-news-stock-tips/1279502/ 2012-02-23 http://campath.legalview.com/news-articles/mid-day-update-stocks-moderately-higher-as-investors-try-to-shake-off/1279501/ 2012-02-23 http://campath.legalview.com/news-articles/top-healthcare-stocks-on-watch-beacon-equity-penny-stocks-stock-alerts/1279500/ 2012-02-23 http://campath.legalview.com/news-articles/sanofi-and-genzyme-appear-close-to-a-deal-nytimescom/1279499/ 2012-02-23 http://campath.legalview.com/news-articles/max-planck-gesellschaft-presseinformation/1235929/ 2012-02-23 http://campath.legalview.com/news-articles/genzyme-rejette-la-proposition-de-rachat-de-sanofi-boursiercom/1235928/ 2012-02-23 http://campath.legalview.com/news-articles/news-from-cambridge-uk/1235927/ 2012-02-23 http://campath.legalview.com/news-articles/british-austrian-scientists-awarded-k-j-z252lch-prize-for-basic-neurol/1235926/ 2012-02-23 http://campath.legalview.com/news-articles/analysten-halten-genzyme-erwartungen-an-ms-mittel-far-aberzogen-dow-jo/1235925/ 2012-02-23 http://campath.legalview.com/news-articles/sanofi-aventis-fr0000120578-san-genzyme-pourrait-surestimer-ses-argume/1235924/ 2012-02-23 http://campath.legalview.com/news-articles/yet-another-reason-that-sanofi-genzyme-deal-will-go-through-bnet/1235923/ 2012-02-23 http://campath.legalview.com/news-articles/heard-on-the-street-sanofi-tries-to-crack-genzymes-code-wsjcom/1235922/ 2012-02-23 http://campath.legalview.com/news-articles/genmab-announces-retirement-of-ceo-tradingmarketscom/1198000/ 2012-02-23 http://campath.legalview.com/news-articles/login-clinical-oncology-news/1197999/ 2012-02-23 http://campath.legalview.com/news-articles/officialwire-pipeline-insight-multiple-sclerosis-risk-benefit-ratio-un/1197998/ 2012-02-23